Atlanta, GA, United States of America

Peter Voet

This inventor holds 4 USPTO granted patents and 2 published patent applications. Top assignee: Elekta, Inc.. Active years: 2025-2026.

USPTO Granted Patents = 4 

% Patents Active = 50.0

Average Co-Inventor Count = 3.3

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Peter Voet

Introduction

Peter Voet is a notable inventor based in Atlanta, GA (US). He has made significant contributions to the field of radiation treatment planning through his innovative patent. His work is instrumental in enhancing the effectiveness of treatment plans for patients undergoing radiation therapy.

Latest Patents

Peter Voet holds a patent for a "Method and system for treatment planning." This computer-implemented method aids in radiation treatment planning by receiving treatment plan parameters, including a reference dose value for a target region of a patient and a defined dose value for a surrounding region. The method determines whether the defined dose value for the surrounding region exceeds a threshold. If it does not exceed the threshold, the method modifies the defined dose value for the surrounding region and applies an optimization procedure to the treatment plan.

Career Highlights

Peter Voet is currently employed at Elekta, Inc., a company known for its advanced medical technology solutions. His work at Elekta focuses on improving radiation treatment planning, which is crucial for patient care in oncology.

Collaborations

Peter has collaborated with talented individuals such as Chunhua Men and Spencer Marshall, contributing to the advancement of technology in the medical field.

Conclusion

Peter Voet's innovative work in radiation treatment planning exemplifies the impact of technology on healthcare. His contributions continue to shape the future of patient treatment methodologies.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…